075586725195  |  Set Home  |  Favorite  |  中文
Case report
Case report
Case5# The PR patient of suffering from glioblastoma with relapse
Date: 2019-10-18

43 year-old male suffering from glioblastoma with relapse

Cancer History:

First diagnosis of cancer: 7.2018  Cancer type GBM, NOS; Stage 4

First recurrence date: 10.2018     Sites: CNS, left temporal lobe mass

Refractory or persistent disease sites: CNS, left temporal lobe

Therapy gone through: Surgery: Yes, gross total resection

Chemotherapy: Temozolomide; radiotherapy: Yes

Clinical Trial Number:NCT03170141; enrolled date: 23/10/2018

Interventions: 4SCAR (CD70, PSMA); neoantigen EIE; DC vaccines

CRS Grade: 0 other side effects: None

Treatment response: PR     Quality of Life: stable

Progression-free interval: 10 months

Current status: Alive with disease

Disease images before and after CART/EIE/DCvac treatment (with time)


ADD: 深圳市南山区粤兴二道6号虚拟大学园重点实验室平台二层   TEL: 075586725195   Email: gimi_trials@szgimi.org

Copyright © 2016 Shenzhen Genoimmune Medical Institute all rights reserved.